Martine A. Rothblatt's Stock Transactions in United Therapeutics Corp

Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp, engaged in multiple stock transactions between October 23 and October 24, 2025. These transactions included the acquisition and disposal of common stock and stock options. Notably, Rothblatt exercised stock options for 4,000 shares at $120.26 per share on both days, while also selling shares at weighted average prices ranging from $421.37 to $426.40. The transactions were executed under a pre-arranged 10b5-1 trading plan established on May 2, 2025. Rothblatt's ownership includes shares held in various family trusts, with total holdings in trusts amounting to 644,193 shares.